Content by The Scientist

Staff Profile : Brendan Maher
The Scientist | | 1 min read
Staff Profile Brendan Maher Senior Editor School/Degree B.A. in Writing and Biology; Loyola College of Maryland When you joined The Scientist

Staff Profile : Alison McCook
The Scientist | | 1 min read
Staff Profile Alison McCook News Editor School/Degree B.S. in Biology, McGill University; M.A. in Science and Environmental Reporting, New York University When you joined The Scientist

Staff Profile : Susan Klumb
The Scientist | | 1 min read
Staff Profile Susan Klumb Advertising and Sales Coordinator School/Degree BA in Communication, University of Delaware When you joined The Scientist

Staff Profile : Maria Anderson
The Scientist | | 1 min read
Staff Profile Maria W. Anderson Assistant Publisher School/Degree B.S., University of Georgia When you joined The Scientist Septem

Staff Profile : Jeffrey S. Myers
The Scientist | | 1 min read
Staff Profile Jeffrey S. Myers Managing Editor School/Degree BA in English, Widener University When you joined The Scientist

Staff Profile : Carol L. Fisher
The Scientist | | 1 min read
Staff Profile Carol L. Fisher Editor of Special Projects, The ScientistEditor of The Pharma Frontier, a Johnson & Johnson Pharmaceutical Research & Development magazine, developed and produced by The Scientist School/Degree Muhlenberg College, BA

Staff Profile : Ishani Ganguli
The Scientist | | 1 min read
Staff Profile Ishani Ganguli Staff Writer School/Degree A.B. in Biochemistry, Harvard University When you joined The Scientist Jun

Staff Profile : Ivan Oransky
The Scientist | | 2 min read
Staff Profile Ivan Oransky Deputy Editor School/Degree Harvard University, A.B. in Biology; New York University, M.D. When you joined The Scientist Jun

Readers respond
The Scientist | | 3 min read
Autoimmunity and cancer, the Estonian genome project, and taking us to task on the Vatican

Pharmaceutical Industry Job Statistics
The Scientist | | 1 min read
Date : December 12, 1994 Back To: Pharmaceutical Companies Stress Innovative Research For Success The Pharmaceutical Research and Manufacturers of America (PhRMA), a trade association of research-based pharmaceutical companies, reports an almost 15 percent reduction in the overall work force in the past two to three years, with current employment totaling 266,000. 19900 19912,700 19925,950 199324,850 199412,880 TOTAL46,380 Ma

Pharmaceutical Industry Job Statistics
The Scientist | | 1 min read
Date : December 12, 1994 Back To: Pharmaceutical Companies Stress Innovative Research For Success The Pharmaceutical Research and Manufacturers of America (PhRMA), a trade association of research-based pharmaceutical companies, reports an almost 15 percent reduction in the overall work force in the past two to three years, with current employment totaling 266,000. 19900 19912,700 19925,950 199324,850 199412,880 TOTAL46,380 Ma

Science Research In 1992: What Fields Were The Hottest Of The Hot?
The Scientist | | 8 min read
RANK PAPER CITATIONS 1 M. Leid, et al., "Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently," Cell, 68(2): 377- 95, 24 January 1992. 58 2 J.D. Brook, et al., "Molecular basis of myotonic dystrophy; Expansion of a trinucleotide (CTG) repeat at the 3 end of a transcript encoding a protein kinase family member," Cell, 68(4):799-808, 20 February 1992. 47 3 W.O. Spitzer, et al., "The use of beta-agonists an

Hot Papers
The Scientist | | 3 min read
1992'S HOTTEST RESEARCH PAPERS RANK PAPER CITATIONS 1 M. Leid, et al., "Purification, cloning, and RXR identity of the HeLa cell factor with which RAR or TR heterodimerizes to bind target sequences efficiently," Cell, 68(2): 377- 95, 24 January 1992. 58 2 J.D. Brook, et al., "Molecular basis of myotonic dystrophy; Expansion of a trinucleotide (CTG) repeat at the 3 end of a transcript encoding a protein kinase family member," Cell, 68(4):799-808, 20 February 1992. 47 3 W.O. S












